Kidney Week

Abstract: TH-PO014

Hyperuricemia Is Associated with AKI and All-Cause Mortality in Hospitalized Patients

Session Information

• AKI: Epidemiology, Risk Factors, Prevention
  October 25, 2018 | Location: Exhibit Hall, San Diego Convention Center
  Abstract Time: 10:00 AM - 12:00 PM

Category: Acute Kidney Injury

• 101 AKI: Epidemiology, Risk Factors, and Prevention

Authors

• Kang, Min woo, Seoul National University Hospital, Seoul, Korea (the Republic of)

Min woo Kang,

• Kang, Minjung, Seoul National University Hospital, Seoul, Korea (the Republic of)

Minjung Kang,

• Kwon, Soie, Seoul national university, Seoul, Korea (the Republic of)

Soie Kwon,

• Chin, Ho Jun, Seoul National University Bundang Hospital, Seong nam, Korea (the Republic of)

Ho Jun Chin,

• Kim, Dong Ki, Seoul National University Hospital, Seoul, Korea (the Republic of)

Dong Ki Kim,

• Joo, Kwon Wook, Seoul National University Hospital, Seoul, Korea (the Republic of)

Kwon Wook Joo,

• Kim, Yon Su, Seoul National University College of Medicine, Seoul, Korea (the Republic of)

Yon Su Kim,

• Kim, Sejoong, Seoul National University Bundang Hospital, Seong nam, Korea (the Republic of)

Sejoong Kim,

• Han, Seung Seok, Seoul National University College of Medicine, Seoul, Korea (the Republic of)

Seung Seok Han,

Background

Hyperuricemia as a risk factor of high morbidity and mortality has been documented in several disease status. Nevertheless, the relationship between uric acid (UA) and the risks of acute kidney injury (AKI) and mortality remains unresolved in hospitalized patients.

Methods

All patients (aged ≥ 17 years old) admitted to Seoul National University Bundang Hospital from January 2013 to December 2013 were retrospectively reviewed. UA at the time of admission was categorized based on the quartiles. Odds ratio (OR) for AKI and hazard ratio (HR) for all-cause mortality were calculated after adjustment of multiple variables. All the analyses were stratified by gender.

Results

The 4th quartile UA group (male, UA ≥ 6.8 mg/dL; female, UA ≥ 5.4 mg/dL) showed a higher risk of AKI than the 1st quartile group (male, UA < 4.4 mg/dL; female, UA < 3.5 mg/dL) as following ORs: 2.3 (1.76-2.90) in males (P < 0.001); and 2.5 (1.86-3.32) in females (P < 0.001).
There were more patients who did not recover from AKI in the 4th quartiles than in the 1st quartiles, as following ORs: 1.5 (1.11-1.95) in males (P < 0.001); and 2.5 (1.63-3.98) in females (P < 0.001).
The 4th quartile group had a higher risk of all-cause mortality than the 1st quartile group, as following HRs: 1.5 (1.30-1.71) in males (P < 0.001); and 1.3 (1.08-1.52) in females (P = 0.004).
The in-hospital mortality risk was also higher in the 4th quartile than in the 1st quartile, which was only significant in males: OR, 2.4 (1.56-3.77) (P < 0.001).

Conclusion

Hyperuricemia increases the risks of AKI and all-cause mortality in hospitalized patients.